Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements Of Redeemable Preferred Stock and Stockholders' Equity (Unaudited)

v3.21.2
Consolidated Statements Of Redeemable Preferred Stock and Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Series F Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Series E Convertible Preferred Stock
Convertible Preferred Stock
Series E Convertible Preferred Stock
Convertible Preferred Stock
Series F Convertible Preferred Stock
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance at Dec. 31, 2019 $ 378   $ 31 $ 235,595       $ (701) $ (234,547)
Beginning balance at Dec. 31, 2019           $ 3,965      
Beginning balance, shares at Dec. 31, 2019           70,000      
Balance (in shares) at Dec. 31, 2019     31,439,000            
Conversion of convertible preferred stock 3,965       $ 3,965 $ (3,965)      
Conversion of convertible preferred stock, shares           70,000      
Sale of common stock 3,861     3,861          
Sale of common stock warrants 3,031     3,031          
Settlement of liability awards 151     151          
Deemed Dividend on Convertible Preferred Stock 0                
Stock offering costs (863)     (863)          
Stock-based compensation 1,348     1,348          
Warrants issued in connection with debt instruments 67     67          
Issuance of stock from RSUs, net 19   $ 19            
Issuance of stock from RSUs, net, shares     18,903,000            
Net loss (10,704)               (10,704)
Foreign currency translation adjustments 56             56  
Ending balance at Jun. 30, 2020 1,309   $ 50 247,155       (645) (245,251)
Balance (in shares) at Jun. 30, 2020     50,342,000            
Beginning balance at Dec. 31, 2019 378   $ 31 235,595       (701) (234,547)
Beginning balance at Dec. 31, 2019           $ 3,965      
Beginning balance, shares at Dec. 31, 2019           70,000      
Balance (in shares) at Dec. 31, 2019     31,439,000            
Sale of common stock, shares   17,000              
Ending balance at Dec. 31, 2020 $ 10,028   $ 98 261,573     $ 118 (385) (251,376)
Balance (in shares) at Dec. 31, 2020 97,709,000   97,709,000       1,000    
Ending balance, shares at Dec. 31, 2020 0 882              
Beginning balance at Mar. 31, 2020 $ (4,856)   $ 31 236,386       (719) (240,554)
Beginning balance at Mar. 31, 2020           $ 3,965      
Beginning balance, shares at Mar. 31, 2020           70,000      
Balance (in shares) at Mar. 31, 2020     31,537,000            
Conversion of convertible preferred stock 3,965       $ 3,965 $ (3,965)      
Conversion of convertible preferred stock, shares           70,000      
Sale of common stock 3,861     3,861          
Sale of common stock warrants 3,031     3,031          
Deemed Dividend on Convertible Preferred Stock 0                
Stock offering costs (863)     (863)          
Stock-based compensation 708     708          
Warrants issued in connection with debt instruments 67     67          
Issuance of stock from RSUs, net 19   $ 19            
Issuance of stock from RSUs, net, shares     18,805,000            
Net loss (4,697)               (4,697)
Foreign currency translation adjustments 74             74  
Ending balance at Jun. 30, 2020 1,309   $ 50 247,155       (645) (245,251)
Balance (in shares) at Jun. 30, 2020     50,342,000            
Beginning balance at Dec. 31, 2020 $ 10,028   $ 98 261,573     $ 118 (385) (251,376)
Beginning balance, shares at Dec. 31, 2020 0 882              
Balance (in shares) at Dec. 31, 2020 97,709,000   97,709,000       1,000    
Conversion of convertible preferred stock     $ 2 619     $ (621)    
Conversion of convertible preferred stock, shares     1,552,000       1,000    
Sale of common stock $ 13,291   $ 14 13,277          
Sale of common stock, shares   18,000 14,000,000            
Issuance of common stock for settlement of liability 510   $ 1 509          
Issuance of common stock for settlement of liability, Shares     500,000            
Deemed Dividend on Convertible Preferred Stock (538)     (538)     $ 538    
Stock-based compensation 2,062     2,062          
Issuance of stock from RSUs, net     $ 2 (2)          
Issuance of stock from RSUs, net, shares     1,781,000            
Exercise of common stock warrants 15,051   $ 34 15,017          
Exercise of common stock warrants, shares     35,694,000            
Net loss (7,603)               (7,603)
Foreign currency translation adjustments (83)             (83)  
Ending balance at Jun. 30, 2021 $ 33,256   $ 151 292,517     35 (468) (258,979)
Balance (in shares) at Jun. 30, 2021 151,236,000   151,236,000            
Ending balance, shares at Jun. 30, 2021 0 261              
Beginning balance at Mar. 31, 2021 $ 33,516   $ 149 292,141     36 (533) (258,277)
Balance (in shares) at Mar. 31, 2021     149,413,000            
Conversion of convertible preferred stock       7     (7)    
Conversion of convertible preferred stock, shares     18,000            
Sale of common stock (1)     (1)          
Deemed Dividend on Convertible Preferred Stock (6)     (6)     6    
Stock-based compensation 366     366          
Issuance of stock from RSUs, net     $ 2 (2)          
Issuance of stock from RSUs, net, shares     1,781,000            
Exercise of common stock warrants 12     12          
Exercise of common stock warrants, shares     24,000            
Net loss (702)               (702)
Foreign currency translation adjustments 65             65  
Ending balance at Jun. 30, 2021 $ 33,256   $ 151 $ 292,517     $ 35 $ (468) $ (258,979)
Balance (in shares) at Jun. 30, 2021 151,236,000   151,236,000            
Ending balance, shares at Jun. 30, 2021 0 261